Barbara H Bardenheier1, Ji Lin2, Xiaohui Zhuo3, Mohammed K Ali4, Theodore J Thompson2, Yiling J Cheng2, Edward W Gregg2. 1. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA bfb7@cdc.gov. 2. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA. 3. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA Merck & Co., North Wales, PA. 4. Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA.
Abstract
OBJECTIVE: To quantify the impact of diabetes status on healthy and disabled years of life for older adults in the U.S. and provide a baseline from which to evaluate ongoing national public health efforts to prevent and control diabetes and disability. RESEARCH DESIGN AND METHODS: Adults (n = 20,008) aged 50 years and older were followed from 1998 to 2012 in the Health and Retirement Study, a prospective biannual survey of a nationally representative sample of adults. Diabetes and disability status (defined by mobility loss, difficulty with instrumental activities of daily living [IADL], and/or difficulty with activities of daily living [ADL]) were self-reported. We estimated incidence of disability, remission to nondisability, and mortality. We developed a discrete-time Markov simulation model with a 1-year transition cycle to predict and compare lifetime disability-related outcomes between people with and without diabetes. Data represent the U.S. population in 1998. RESULTS: From age 50 years, adults with diabetes died 4.6 years earlier, developed disability 6-7 years earlier, and spent about 1-2 more years in a disabled state than adults without diabetes. With increasing baseline age, diabetes was associated with significant (P < 0.05) reductions in the number of total and disability-free life-years, but the absolute difference in years between those with and without diabetes was less than at younger baseline age. Men with diabetes spent about twice as many of their remaining years disabled (20-24% of remaining life across the three disability definitions) as men without diabetes (12-16% of remaining life across the three disability definitions). Similar associations between diabetes status and disability-free and disabled years were observed among women. CONCLUSIONS: Diabetes is associated with a substantial reduction in nondisabled years, to a greater extent than the reduction of longevity.
OBJECTIVE: To quantify the impact of diabetes status on healthy and disabled years of life for older adults in the U.S. and provide a baseline from which to evaluate ongoing national public health efforts to prevent and control diabetes and disability. RESEARCH DESIGN AND METHODS: Adults (n = 20,008) aged 50 years and older were followed from 1998 to 2012 in the Health and Retirement Study, a prospective biannual survey of a nationally representative sample of adults. Diabetes and disability status (defined by mobility loss, difficulty with instrumental activities of daily living [IADL], and/or difficulty with activities of daily living [ADL]) were self-reported. We estimated incidence of disability, remission to nondisability, and mortality. We developed a discrete-time Markov simulation model with a 1-year transition cycle to predict and compare lifetime disability-related outcomes between people with and without diabetes. Data represent the U.S. population in 1998. RESULTS: From age 50 years, adults with diabetes died 4.6 years earlier, developed disability 6-7 years earlier, and spent about 1-2 more years in a disabled state than adults without diabetes. With increasing baseline age, diabetes was associated with significant (P < 0.05) reductions in the number of total and disability-free life-years, but the absolute difference in years between those with and without diabetes was less than at younger baseline age. Men with diabetes spent about twice as many of their remaining years disabled (20-24% of remaining life across the three disability definitions) as men without diabetes (12-16% of remaining life across the three disability definitions). Similar associations between diabetes status and disability-free and disabled years were observed among women. CONCLUSIONS:Diabetes is associated with a substantial reduction in nondisabled years, to a greater extent than the reduction of longevity.
Authors: Edward W Gregg; Xiaohui Zhuo; Yiling J Cheng; Ann L Albright; K M Venkat Narayan; Theodore J Thompson Journal: Lancet Diabetes Endocrinol Date: 2014-08-12 Impact factor: 32.069
Authors: Stefano Volpato; Caroline Blaum; Helaine Resnick; Luigi Ferrucci; Linda P Fried; Jack M Guralnik Journal: Diabetes Care Date: 2002-04 Impact factor: 19.112
Authors: E W Gregg; G L Beckles; D F Williamson; S G Leveille; J A Langlois; M M Engelgau; K M Narayan Journal: Diabetes Care Date: 2000-09 Impact factor: 19.112
Authors: Rita Rastogi Kalyani; Christopher D Saudek; Frederick L Brancati; Elizabeth Selvin Journal: Diabetes Care Date: 2010-02-25 Impact factor: 19.112
Authors: Linda S Geiss; Jing Wang; Yiling J Cheng; Theodore J Thompson; Lawrence Barker; Yanfeng Li; Ann L Albright; Edward W Gregg Journal: JAMA Date: 2014-09-24 Impact factor: 56.272
Authors: Yiling J Cheng; Giuseppina Imperatore; Linda S Geiss; Jing Wang; Sharon H Saydah; Catherine C Cowie; Edward W Gregg Journal: Diabetes Care Date: 2013-05-01 Impact factor: 19.112
Authors: Rachel A Wolf; J Sonya Haw; Sudeshna Paul; Melissa Spezia Faulkner; EunSeok Cha; M K Findley; Farah Khan; Sara Markley Webster; Anastasia-Stefania Alexopoulos; Komal Mehta; David A Alfa; Mohammed K Ali Journal: Diabetes Res Clin Pract Date: 2019-09-24 Impact factor: 5.602
Authors: Edward W Gregg; Ji Lin; Barbara Bardenheier; Haiying Chen; W Jack Rejeski; Xiaohui Zhuo; Andrea L Hergenroeder; Stephen B Kritchevsky; Anne L Peters; Lynne E Wagenknecht; Edward H Ip; Mark A Espeland Journal: Diabetes Care Date: 2018-03-15 Impact factor: 19.112
Authors: Mohammed K Ali; Frank Wharam; O Kenrik Duru; Julie Schmittdiel; Ronald T Ackermann; Jeanine Albu; Dennis Ross-Degnan; Christine M Hunter; Carol Mangione; Edward W Gregg Journal: Curr Diab Rep Date: 2018-11-20 Impact factor: 4.810
Authors: Jessica C G Bak; Dick Mul; Erik H Serné; Harold W de Valk; Theo C J Sas; Petronella H Geelhoed-Duijvestijn; Mark H H Kramer; Max Nieuwdorp; Carianne L Verheugt Journal: BMC Endocr Disord Date: 2021-06-16 Impact factor: 2.763
Authors: Barbara H Bardenheier; Ji Lin; Xiaohui Zhuo; Mohammed K Ali; Theodore J Thompson; Yiling J Cheng; Edward W Gregg Journal: Lancet Diabetes Endocrinol Date: 2016-06-10 Impact factor: 32.069